Claims
- 1. A 6,13-dihydroquinacridone derivative of formula I:(MO3S)m—Q—[CH2—(X)—(Y)n]o (I) wherein:Q represents a 6,13-dihydroquinacridone moiety of formula II; A and B each independently represent a substituent selected from H, F, Cl, C1-C3alkyl and C1-C3alkoxy M represents a metal cation, quaternary N cation or H; X is an aromatic group, a cyclo-hetero aliphatic group with at least one 5 atom or 6 atom ring or a hetero aromatic group with at least one 5 or 6 atom ring and which is not a phthalimido group; Y is a sulfonic or carboxylic acid or salt thereof; m and n independently from each other are a number from zero to 2.5; and o is a number from zero to 4, and where m is not zero.
- 2. A 6,13-dihydroquinacridone derivative of claim 1, wherein the substituents A and B of formula II are each H.
- 3. A 6,13-dihydroquinacridone derivative of claim 1, wherein the metal cation M is sodium, potassium, calcium, magnesium or aluminum.
- 4. A 6,13-dihydroquinacridone derivative of claim 1, wherein X is an aromatic group selected from a 5 carbon or 6 carbon ring or a polycyclic group comprising two to six fused 5 carbon and/or 6 carbon rings.
- 5. A 6,13-dihydroquinacridone derivative of claim 1, wherein the aromatic group is phenylene, naphthalene, anthracene, phenanthrene, pyrene or perylene.
- 6. A 6,13-dihydroquinacridone derivative of claim 5, wherein the aromatic group is phenylene or naphthalene.
- 7. A 6,13-dihydroquinacridone derivative of claim 1, wherein said cyclo-hetero aliphatic group comprises at least one 5 or 6 atom ring.
- 8. A 6,13-dihydroquinacridone derivative of claim 5, wherein said cyclo-hetero aliphatic group is barbituric acid.
- 9. A 6,13-dihydroquinacridone derivative of claim 1, wherein said hetero aromatic group which is not a phthalimido group comprises a 5 or 6 atom ring or fused 5 and/or 6 atom rings and contains 1 to 4 hetero atoms selected from N, S and/or O.
- 10. A 6,13-dihydroquinacridone derivative of claim 9, wherein the hetero aromatic group is a pyridine, quinoline, pyrrole, imidazole or pyrazole group.
- 11. A 6,13-dihydroquinacridone derivative of claim 1, wherein said aromatic, cyclo-hetero aliphatic or hetero aromatic group is optionally substituted with one or more halogen, oxy, hydroxy, imino, amino, C1-C18alkyl or C1-C18alkoxy groups.
- 12. A 6,13-dihydroquinacridone derivative of claim 11, wherein said aromatic, cyclo-hetero aliphatic or hetero aromatic group is optionally substituted with one or more C1-C3alkyl or C1-C3alkoxy groups.
- 13. A 6,13-dihydroquinacridone derivative of claim 1, wherein said aromatic group is toluene, ortho- meta- or para-xylene, chlorobenzene, 1- or 2-methylnaphthalene or anthraquinone.
- 14. A 6,13-dihydroquinacridone derivative of claim 1, wherein said hetero aromatic group is derived from melamine, 1,3,7-trimethylxanthin, hydantoin, 2-methylbenzimidazole, 2,6,8-trihydroxypurine, 1,8-naphtosultam, o-benzoic acid sulfimide or 2,4-dihydroxyprimidine.
- 15. A 6,13-dihydroquinacridone derivative of claim 1, wherein said group Y is a free carboxylic acid or sulfonic acid group or a sodium, potassium, magnesium, calcium, aluminum, quaternary ammonium or alkyl ammonium salt thereof.
- 16. A 6,13-dihydroquinacridone derivative of claim 15, wherein said group Y is a free sulfonic acid group or a sodium, potassium or aluminum salt thereof.
- 17. A mixture of 6,13-dihydroquinacridone derivatives according to claim 1, wherein m is on average from zero to 1, n is on average from zero to 1.2, and o is on average from zero to 1.5.
- 18. A process for the preparation of 6,13-dihydroquinacridone derivative of claim 1, whereby:A) the 6,13-dihydroquinacridone moiety Q is dissolved in concentrated sulfuric acid; B) the intermediate X is optionally added into the solution and dissolved at a temperature below 50° C.; C) para-formaldehyde is optionally added at a temperature below 50° C.; the mixture of step C) is heated to 50 to 100° C.; and the resulting precipitate is isolated.
- 19. A process according to claim 18 wherein the mixture in step C is heated for about 30 minutes to 6 hours and wherein the process further comprises the step of drowning the reaction mixture from step D in water to produce a precipitate.
- 20. A process for the preparation of a 6,13-dihydroquinacridone derivative of claim 18, wherein the molar ratio of 6,13-dihydroquinacridone:intermediate X:formaldehyde is 1:1 to 1.2:1 to 2.
Parent Case Info
This application claims benefit of Provisional appl. 60/118,419, filed Feb. 2, 1999.
US Referenced Citations (5)
Foreign Referenced Citations (6)
Number |
Date |
Country |
0 685 530 |
Dec 1995 |
EP |
0 643 110 |
Jan 1999 |
EP |
1 544 839 |
Apr 1979 |
GB |
61-168666 |
Jul 1986 |
JP |
6-145546 |
May 1994 |
JP |
9841582 |
Sep 1998 |
WO |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/118419 |
Feb 1999 |
US |